A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients
Clinical trial NCT02604355 · TERMINATED
Trial details
- NCT number
- NCT02604355
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-28
- Primary completion
- 2016-05-09
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.